e-learning
resources
Vienna 2012
Sunday, 02.09.2012
New mechanisms in non-neoplastic and neoplastic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulation of microRNA-mRNA target pairs in a model of bronchopulmonary dysplasia
C. Collura, W. Carey, J. Dong, Y.S. Prakash, D. Wigle (Rochester, United States Of America)
Source:
Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Session:
New mechanisms in non-neoplastic and neoplastic lung diseases
Session type:
Oral Presentation
Number:
1400
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Collura, W. Carey, J. Dong, Y.S. Prakash, D. Wigle (Rochester, United States Of America). Regulation of microRNA-mRNA target pairs in a model of bronchopulmonary dysplasia. Eur Respir J 2012; 40: Suppl. 56, 1400
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
Related content which might interest you:
Prediction of bronchopulmonary dysplasia
Source: Annual Congress 2009 - Neonatal respiratory disorders
Year: 2009
Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
Polymorphisms of ADRB2 gene and airway resistance in children with bronchopulmonary dysplasia
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015
Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia
Source: ERS Lung Science Conference 2017
Year: 2017
Urinary metabolomics identifies molecular signatures associated with bronchopulmonary dysplasia (BPD) and birth-term
Source: Virtual Congress 2020 – Airway development in health and disease
Year: 2020
Evolution of lung function in preterm infants with or without bronchopulmonary dysplasia
Source: Annual Congress 2011 - New insights in paediatric respiratory physiology
Year: 2011
Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia.
Source: International Congress 2017 – Infant lung disease: physiology, assessment and novel therapies
Year: 2017
Refinement of the hyperoxia-based experimental mouse model of bronchopulmonary dysplasia
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia
Source: ERJ Open Res, 6 (4) 00157-2020; 10.1183/23120541.00157-2020
Year: 2020
Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia
Source: Eur Respir J 2007; 30: Suppl. 51, 55s
Year: 2007
Lung function abnormalities in infants developing bronchopulmonary dysplasia
Source: Annual Congress 2010 - Paediatric and neonatal intensive care
Year: 2010
Pathogenesis of bronchopulmonary dysplasia
Source: Eur Respir Monogr 2021; 92: 50-67
Year: 2021
Transglutaminase 2: a new player in bronchopulmonary dysplasia?
Source: Eur Respir J 2014; 44: 109-121
Year: 2014
Sensitivity and specificity of a CT scoring system for bronchopulmonary dysplasia and its relationship with lung function
Source: Annual Congress 2010 - Paediatric and neonatal intensive care
Year: 2010
Functional capacity in pre-term bronchopulmonary dysplasia
Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems
Year: 2010
Clinical analysis of premature newborns displaying bronchopulmonary dysplasia
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010
LSC - 2017 - Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
P16 in bronchopulmonary dysplasia: Early determinant of respiratory disease?
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Research lung function for children with bronchopulmonary dysplasia in the past
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Long term management of bronchopulmonary dysplasia
Source: ERS Webinar 2020: Long term management of bronchopulmonary dysplasia
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept